Anderson Hoagland & CO Vir Biotechnology, Inc. Transaction History

Anderson Hoagland & CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$25.51 - $43.38 $855,860 - $1.46 Million	-33,550 Closed	0 $0
Q3 2020 Oct 06, 2020	SELL	$28.28 - $53.6 $25,452 - $48,240	-900 Reduced 2.61%	33,550 $1.38 Million
Q2 2020 Jul 06, 2020	BUY	$27.89 - $47.86 $960,810 - $1.65 Million	34,450 New	34,450 $1.41 Million

220

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.06B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Anderson Hoagland & CO, based on Form 13F filings with the SEC.

Stay updated on Anderson Hoagland & CO with notifications on news.